Intuitive Surgical Inc
ISRGToday
-0.85%
5 Days
-1.58%
1 Month
-1.88%
6 Months
-25.19%
Year to Date
-35.25%
1 Year
-21.45%
Recent
Analysis
Intuitive Surgical Inc Stock (ISRG) Moved Down by 4.89% on Aug 20: What Signal Does It Send?
• Competitors received regulatory clearances, increasing market share concerns for Intuitive Surgical. • Management maintained conservative full-year guidance despite robust quarterly operational metrics. • Wall Street brokerages revised price targets downward due to hospital capital expenditure caution.
CVS Health Corp Stock (CVS) Moved Down by 3.46% on Aug 17: A Full Analysis
• CVS Health faced selling pressure despite raising its full-year earnings guidance. • Investors remain cautious regarding medical cost trends and Caremark structural changes. • Technical indicators show negative momentum with a MACD value of -2.245.
Cencora Inc Stock (COR) Closed Down by 5.92% on Aug 12: Key Drivers Unveiled
• Cencora stock fell as non-prime Walgreens pharmaceutical volume moved to competitors. • Investors focused on revenue risks despite reiterated full-year earnings per share guidance. • Cencora reported $321.33B in annual revenue, ranking first in its industry.
Intuitive Surgical Inc Stock (ISRG) Moved Up by 3.01% on Aug 10: A Full Analysis
• Intuitive Surgical shares rose due to increased global procedure volumes and institutional demand. • Stable hospital capital expenditure and recurring revenue models support the company’s financial growth. • Analysts maintain a Buy rating with an average price target of $480.08.
Resmed Inc Stock (RMD) Moved Up by 3.01% on Aug 10: Key Drivers Unveiled
• ResMed reported strong recurring revenue from its AirSense platform and software ecosystem. • Clinical insights suggest GLP-1 drugs increase sleep apnea diagnosis rates and patient engagement. • ResMed solidified market share as its primary competitor faces ongoing regulatory constraints.
Stryker Corp Stock (SYK) Moved Up by 4.41% on Aug 3: What Investors Need To Know
• Stryker exceeded second-quarter earnings expectations across MedSurg and Neurotechnology segments. • Management raised full-year earnings guidance citing operational efficiencies and market share gains. • Analysts maintain a Buy rating with an average price target of $385.60.
Intuitive Surgical Inc's Score
Media Coverage
Analyst Rating
Intuitive Surgical Inc Technical Analysis
Technical Indicators
Summary
Moving Average
Financial Indicators
Earnings
Intuitive Surgical Inc Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.52% |
| BlackRock Institutional Trust Company, N.A. | 5.32% |
| State Street Investment Management (US) | 4.43% |
| T. Rowe Price Associates, Inc. | 3.40% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 50.32% |
| Investment Advisor/Hedge Fund | 26.27% |
| Hedge Fund | 3.22% |
| Pension Fund | 2.76% |
Related Instruments
Popular Instruments
